Wilson Sonsini Goodrich & Rosati advised InCarda Therapeutics, Inc. on the deal. InCarda Therapeutics, Inc., a privately held biopharmaceutical company developing first-of-their-kind inhaled therapies for cardiovascular…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
